IBDEI2J7 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,40419,1,3,0)
 ;;=3^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,40419,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,40419,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,40420,0)
 ;;=F18.10^^152^2012^100
 ;;^UTILITY(U,$J,358.3,40420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40420,1,3,0)
 ;;=3^Inhalant Abuse,Uncomplicated
 ;;^UTILITY(U,$J,358.3,40420,1,4,0)
 ;;=4^F18.10
 ;;^UTILITY(U,$J,358.3,40420,2)
 ;;=^5003380
 ;;^UTILITY(U,$J,358.3,40421,0)
 ;;=F55.0^^152^2012^42
 ;;^UTILITY(U,$J,358.3,40421,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40421,1,3,0)
 ;;=3^Antacid Abuse
 ;;^UTILITY(U,$J,358.3,40421,1,4,0)
 ;;=4^F55.0
 ;;^UTILITY(U,$J,358.3,40421,2)
 ;;=^5003628
 ;;^UTILITY(U,$J,358.3,40422,0)
 ;;=F18.90^^152^2012^101
 ;;^UTILITY(U,$J,358.3,40422,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40422,1,3,0)
 ;;=3^Inhalant Use Uncomplicated,Unspec
 ;;^UTILITY(U,$J,358.3,40422,1,4,0)
 ;;=4^F18.90
 ;;^UTILITY(U,$J,358.3,40422,2)
 ;;=^5003405
 ;;^UTILITY(U,$J,358.3,40423,0)
 ;;=F55.2^^152^2012^107
 ;;^UTILITY(U,$J,358.3,40423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40423,1,3,0)
 ;;=3^Laxative Abuse
 ;;^UTILITY(U,$J,358.3,40423,1,4,0)
 ;;=4^F55.2
 ;;^UTILITY(U,$J,358.3,40423,2)
 ;;=^5003630
 ;;^UTILITY(U,$J,358.3,40424,0)
 ;;=F55.1^^152^2012^86
 ;;^UTILITY(U,$J,358.3,40424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40424,1,3,0)
 ;;=3^Herbal/Folk Remedy Abuse
 ;;^UTILITY(U,$J,358.3,40424,1,4,0)
 ;;=4^F55.1
 ;;^UTILITY(U,$J,358.3,40424,2)
 ;;=^5003629
 ;;^UTILITY(U,$J,358.3,40425,0)
 ;;=F55.8^^152^2012^129
 ;;^UTILITY(U,$J,358.3,40425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40425,1,3,0)
 ;;=3^Non-Psychoactive Substance Abuse
 ;;^UTILITY(U,$J,358.3,40425,1,4,0)
 ;;=4^F55.8
 ;;^UTILITY(U,$J,358.3,40425,2)
 ;;=^5003633
 ;;^UTILITY(U,$J,358.3,40426,0)
 ;;=F55.4^^152^2012^168
 ;;^UTILITY(U,$J,358.3,40426,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40426,1,3,0)
 ;;=3^Vitamin Abuse
 ;;^UTILITY(U,$J,358.3,40426,1,4,0)
 ;;=4^F55.4
 ;;^UTILITY(U,$J,358.3,40426,2)
 ;;=^5003632
 ;;^UTILITY(U,$J,358.3,40427,0)
 ;;=F55.3^^152^2012^158
 ;;^UTILITY(U,$J,358.3,40427,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40427,1,3,0)
 ;;=3^Steroid/Hormone Abuse
 ;;^UTILITY(U,$J,358.3,40427,1,4,0)
 ;;=4^F55.3
 ;;^UTILITY(U,$J,358.3,40427,2)
 ;;=^5003631
 ;;^UTILITY(U,$J,358.3,40428,0)
 ;;=F51.09^^152^2012^102
 ;;^UTILITY(U,$J,358.3,40428,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40428,1,3,0)
 ;;=3^Insomnia not d/t Substance/Known Physiol Condition
 ;;^UTILITY(U,$J,358.3,40428,1,4,0)
 ;;=4^F51.09
 ;;^UTILITY(U,$J,358.3,40428,2)
 ;;=^5003608
 ;;^UTILITY(U,$J,358.3,40429,0)
 ;;=H53.9^^152^2012^166
 ;;^UTILITY(U,$J,358.3,40429,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40429,1,3,0)
 ;;=3^Visual Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,40429,1,4,0)
 ;;=4^H53.9
 ;;^UTILITY(U,$J,358.3,40429,2)
 ;;=^124001
 ;;^UTILITY(U,$J,358.3,40430,0)
 ;;=I89.0^^152^2012^118
 ;;^UTILITY(U,$J,358.3,40430,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40430,1,3,0)
 ;;=3^Lymphedema NEC
 ;;^UTILITY(U,$J,358.3,40430,1,4,0)
 ;;=4^I89.0
 ;;^UTILITY(U,$J,358.3,40430,2)
 ;;=^5008073
 ;;^UTILITY(U,$J,358.3,40431,0)
 ;;=I87.1^^152^2012^165
 ;;^UTILITY(U,$J,358.3,40431,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40431,1,3,0)
 ;;=3^Vein Compression
 ;;^UTILITY(U,$J,358.3,40431,1,4,0)
 ;;=4^I87.1
 ;;^UTILITY(U,$J,358.3,40431,2)
 ;;=^269850
